These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3968854)

  • 21. Pharmacokinetics and pharmacodynamics of cimetidine and metabolites in critically ill children.
    Lloyd CW; Martin WJ; Taylor BD; Hauser AR
    J Pediatr; 1985 Aug; 107(2):295-300. PubMed ID: 4020559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between cimetidine plasma levels and gastric acidity in acutely ill patients.
    Cohen IA; Siepler JK; Nation R; Bombeck CT; Nyhus LM
    Am J Hosp Pharm; 1980 Mar; 37(3):375-9. PubMed ID: 7369219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients.
    Sandborn WJ; Forland SC; Cutler RE; Strong RM
    J Clin Pharmacol; 1990 Jun; 30(6):568-71. PubMed ID: 2355107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of teicoplanin in burn patients.
    Potel G; Moutet J; Bernareggi A; Le Normand Y; Meigner M; Baron D
    Scand J Infect Dis Suppl; 1990; 72():29-34. PubMed ID: 2151064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
    J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased nonrenal clearance of cimetidine during antituberculous therapy.
    Keller E; Schollmeyer P; Brandenstein U; Hoppe-Seyler G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):307-11. PubMed ID: 6746154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lorazepam conjugation is unimpaired in burn trauma.
    Martyn J; Greenblatt DJ
    Clin Pharmacol Ther; 1988 Mar; 43(3):250-5. PubMed ID: 3345616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age and renal clearance of cimetidine.
    Drayer DE; Romankiewicz J; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1982 Jan; 31(1):45-50. PubMed ID: 7053303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combination of antacid and cimetidine on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
    Mahachai V; Jamali F; Thomson AB
    Clin Ther; 1984; 6(6):808-23. PubMed ID: 6391667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of interaction between verapamil and cimetidine.
    Abernethy DR; Schwartz JB; Todd EL
    Clin Pharmacol Ther; 1985 Sep; 38(3):342-9. PubMed ID: 4028631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent pharmacokinetics of cimetidine in the rat.
    Adedoyin A; Aarons L; Houston JB
    Xenobiotica; 1987 May; 17(5):595-604. PubMed ID: 3604263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cimetidine in critically ill patients.
    Nation RL; Ilett KF; Tjokrosetio R; Oh TE; Cameron P; Thompson W
    Eur J Clin Pharmacol; 1984; 26(3):341-6. PubMed ID: 6734696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cimetidine pharmacokinetics].
    Katrukha SP; Karpenko EV; Davydov SM; Blinkov IL; Kukes VG
    Farmakol Toksikol; 1986; 49(5):36-40. PubMed ID: 3770173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebound following hemodialysis of cimetidine and its metabolites.
    Ziemniak JA; Cersosimo RJ; Russo J; Moran DM; Kablitz C; Schentag JJ
    Am J Kidney Dis; 1984 May; 3(6):430-5. PubMed ID: 6720687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cimetidine clearance in the obese.
    Bauer LA; Wareing-Tran C; Edwards WA; Raisys V; Ferreri L; Jack R; Dellinger EP; Simonowitz D
    Clin Pharmacol Ther; 1985 Apr; 37(4):425-30. PubMed ID: 3979004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.